New Protein Biomarkers for Histopathological Classification of Breast Cancer

Poster   Oct 08, 2007

 
New Protein Biomarkers for Histopathological Classification of Breast Cancer
 
View Poster
 
 

 
 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

 
View Poster
 

This content appears on:

Analysis & Separations Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

OTHER POSTERS

Automating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycan

Poster

One of the emerging trends in glycomics research is the innovation related to accurate MS based quantitative analysis of glycans.

READ MORE

Can a Unified Laboratory Intelligence Approach be Applied to E&L Studies?

Poster

Informatics technologies and software automation of workflows are becoming key strategic considerations for identification, elucidation, and characterization of extractables and leachables.

READ MORE

Inecalcitol Stimulates CD38 Expression in Multiple Myeloma and Acute Myeloid Leukemia Cell Lines

Poster

Inecalcitol is a vitamin D receptor agonist currently in Phase II clinical trial in AML (acute myeloid leukemia). Inecalcitol increases the expression of CD38 at the surface of 5 multiple myeloma cell lines; therefore, inecalcitol could potentiate the clinical response of MM patients to a therapeutic anti-CD38 antibody
Inecalcitol induces the expression of the CD38 antigen at the surface of 4 AML cell lines; thus, inecalcitol could render AML patients sensitive to a therapeutic anti-CD38.

READ MORE

 

Comments | 0 ADD COMMENT